Thursday, February 2, 2017

Enzyme deficiency target of autism study

... one of over 30 sites across the U.S. participating in a study run by Curemark. A biopharmaceutical company based in Rye, New York, Curemark focuses on neurological developmental disorders, such as Parkinson's disease and schizophrenia, in addition ...
http://ift.tt/2kx6SXM

No comments:

Post a Comment

Popular Rye NY Posts